FHJVX | VEURX | FHJVX / VEURX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 11 years | 34 years | - |
Gain YTD | 9.202 | 6.896 | 133% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 621M | 26.1B | 2% |
Annual Yield % from dividends | 0.89 | 3.11 | 29% |
Returns for 1 year | 20.66 | 18.82 | 110% |
Returns for 3 years | -15.70 | 1.57 | -1,001% |
Returns for 5 years | 8.45 | 26.77 | 32% |
Returns for 10 years | 12.19 | 37.51 | 32% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ICTEX | 17.04 | 0.18 | +1.07% |
ICON Health and Information Tech Instl | |||
BRSDX | 16.13 | 0.16 | +1.00% |
MFS Blended Research Small Cap Eq A | |||
VTWIX | 245.02 | 1.25 | +0.51% |
Vanguard Total World Stock Index I | |||
RLIEX | 17.95 | 0.05 | +0.28% |
Lazard International Equity R6 | |||
JSCRX | 19.85 | N/A | N/A |
PGIM Jennison Small Company R |